| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |